Depletion

Depletion describes what happens when a neuron's internal stores of a neurotransmitter fall below the level needed for normal signalling. Neurons package their chemical messengers into tiny membrane-bound sacs called vesicles; when a substance forces those vesicles to empty faster than new transmitter can be synthesised from scratch, the reserves run low.

The term is most often applied to the monoamines — serotonin, dopamine, and norepinephrine — which share a common vulnerability: their synthesis depends on enzymatic steps and dietary amino acid precursors, making rapid replenishment impossible. It is the conventional explanation for the fatigue, flat mood, and poor concentration that follow heavy use of certain stimulants and entactogens, though the recovery timeline is better established than the precise mechanism.

How it works · its role

Under normal conditions, neurons synthesise their transmitter continuously and store it in vesicles, ready for release on demand. When a substance triggers mass release — or blocks the machinery that repackages transmitter back into vesicles — the stores empty faster than they can be refilled.

Replenishment requires the full synthesis pathway: dietary precursors (tryptophan for serotonin, tyrosine for dopamine) must be absorbed, transported into the neuron, and converted through several enzymatic steps before the finished transmitter can be repackaged by a protein called the vesicular monoamine transporter, or VMAT. Each stage takes time. Until the cycle completes, the neuron has less to release, and signalling is blunted — even if the receptors that would receive it remain intact and available.

Relevance to substances & effects

Depletion is most associated with MDMA and related entactogens, which cause a simultaneous, large-scale release of serotonin, dopamine, and norepinephrine. The acute emotional warmth and stimulation these substances produce reflects how much transmitter is flooding the synapse; the low mood, mental fog, and fatigue that can follow — sometimes called a comedown — are widely attributed to the resulting shortfall in those same monoamines.

Amphetamines and other substituted phenethylamines can produce similar dopamine and norepinephrine depletion with heavy or repeated use. Cocaine, which works primarily by blocking reuptake rather than forcing vesicular release, is thought to cause less depletion per episode, though binge patterns can still exhaust available stores.

Classic psychedelics such as LSD and psilocin do not cause significant monoamine depletion — they act at receptors rather than driving mass release — so the fatigue sometimes reported after a long psychedelic session has different proposed causes.

Tolerance & dependence

Depletion is a temporary state: stores refill as the synthesis pathways run. With adequate rest and nutrition, mild depletion from a single episode is generally expected to resolve within a few days. Heavier use, or use repeated before stores have recovered, prolongs the shortfall and may extend the period of blunted mood and energy.

Allowing sufficient time between uses is a core principle in entactogen harm reduction for this reason. It is also worth distinguishing depletion from receptor downregulation, which can occur in parallel. Both contribute to the dulled response sometimes called tolerance, but through different mechanisms and on different timescales — depletion is a supply problem; downregulation is a sensitivity problem.

Whether repeated cycles of depletion produce changes that outlast the recovery window remains an open question in the research literature. The short-term picture is reasonably clear; the long-term picture, less so.